NEXTBIOMEDICAL Announces First Patient Enrolled in U.S. FDA Pivotal Trial of Nexsphere-F™ for Knee Osteoarthritis Pain

The study is designed to compare genicular artery embolization (GAE) with Nexsphere-F™ to intra-articular corticosteroid injections, with the primary goal of assessing both safety and efficacy in patients with painful knee osteoarthritis. Nexsphere-F™ has already received multiple key U.S. regulatory designations, including FDA Breakthrough Device Designation, CMS IDE Category B approval, and participation in the TAP (Total Product Lifecycle Advisory Program).

How to Become a Better Nurse

Article on how to become a better nurse

If you are currently working in the field of nursing, then congratulations and well done! To say that nursing can be a challenging and difficult job is an understatement. This is because the job is usually one that is extremely fast-paced but also physically and mentally demanding. However, it is important to note that despite […]